{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:01:27Z","timestamp":1793314887620,"version":"4.5.0"},"reference-count":219,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01HD094395"],"award-info":[{"award-number":["R01HD094395"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["957261"],"award-info":[{"award-number":["957261"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clim.2023.109745","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T11:34:17Z","timestamp":1692790457000},"page":"109745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The pathogenesis of obstetric APS: a 2023 update"],"prefix":"10.1016","volume":"255","author":[{"given":"Chieko","family":"Mineo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Shaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie L.","family":"Bermas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2023.109745_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2023.109745_bb0010","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","author":"Practice Committee of the American Society for Reproductive M","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.clim.2023.109745_bb0015","first-page":"24","article-title":"Antiphospholipid syndrome in pregnancy: new and old pathogenetic mechanisms","author":"D\u2019Ippolito","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2023.109745_bb0020","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.autrev.2018.12.006","article-title":"The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 1000 consecutive cases","volume":"18","author":"Alijotas-Reig","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb0025","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1073\/pnas.88.8.3069","article-title":"Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies","volume":"88","author":"Blank","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2023.109745_bb0030","first-page":"100","article-title":"Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies","volume":"21","author":"Blank","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2023.109745_bb0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9378(11)90700-5","article-title":"Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB\/c mice: a model for autoimmune fetal loss","volume":"163","author":"Branch","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clim.2023.109745_bb0040","first-page":"11","article-title":"Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: a comprehensive review","author":"Alijotas-Reig","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.clim.2023.109745_bb0045","first-page":"CD012852","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","volume":"5","author":"Hamulyak","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb0050","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/jth.15290","article-title":"Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome-What is the evidence?","volume":"19","author":"Hamulyak","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2023.109745_bb0055","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/j.thromres.2009.11.030","article-title":"Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy","volume":"125","author":"Oberkersch","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2023.109745_bb0060","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2023.109745_bb0065","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","article-title":"Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin","volume":"26","author":"Stephenson","year":"2004","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.clim.2023.109745_bb0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijgo.2010.09.010","article-title":"Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome","volume":"112","author":"Fouda","year":"2011","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.clim.2023.109745_bb0075","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","article-title":"Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin","volume":"83","author":"Noble","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.clim.2023.109745_bb0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.autrev.2015.01.008","article-title":"Histopathology in the placentae of women with antiphospholipid antibodies: a systematic review of the literature","volume":"14","author":"Viall","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb0085","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/humrep\/17.4.1067","article-title":"Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure","volume":"17","author":"Sebire","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.clim.2023.109745_bb0090","series-title":"Hughes\u2019 Syndrome","article-title":"Placental pathology in antiphospholipid syndrome","author":"Parke","year":"2006"},{"key":"10.1016\/j.clim.2023.109745_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.852777","article-title":"Risk of thrombosis, pregnancy morbidity or death in antiphospholipid syndrome","volume":"9","author":"Killian","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.clim.2023.109745_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103101","article-title":"Antiphospholipid antibodies in women with recurrent embryo implantation failure: a systematic review and meta-analysis","volume":"21","author":"Jarne-Borras","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb0105","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1055\/a-1701-2809","article-title":"Pathophysiology of antiphospholipid syndrome","volume":"122","author":"Green","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.clim.2023.109745_bb0110","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.abg6449","article-title":"Linking clotting and autoimmunity","volume":"371","author":"Kaplan","year":"2021","journal-title":"Science."},{"key":"10.1016\/j.clim.2023.109745_bb0115","first-page":"1290","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"379","author":"Garcia","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2023.109745_bb0120","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151","author":"Cervera","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2023.109745_bb0125","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.autrev.2014.05.004","article-title":"Obstetric antiphospholipid syndrome: a recent classification for an old defined disorder","volume":"13","author":"D\u2019Ippolito","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/humupd\/dmu049","article-title":"Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment","volume":"21","author":"Tong","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.clim.2023.109745_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13509","article-title":"Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome","volume":"87","author":"Fierro","year":"2022","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0378(92)90002-L","article-title":"Monoclonal antiphospholipid antibody reactivity against human placental trophoblast","volume":"22","author":"Lyden","year":"1992","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0145","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1182\/blood-2011-01-333617","article-title":"In vivo distribution of beta2 glycoprotein I under various pathophysiologic conditions","volume":"118","author":"Agostinis","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41584-018-0032-6","article-title":"Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?","volume":"14","author":"Meroni","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2023.109745_bb0155","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.blre.2017.07.006","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"31","author":"Chaturvedi","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.clim.2023.109745_bb0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.placenta.2020.02.007","article-title":"Trophoblast lineage-specific differentiation and associated alterations in preeclampsia and fetal growth restriction","volume":"102","author":"Farah","year":"2020","journal-title":"Placenta."},{"key":"10.1016\/j.clim.2023.109745_bb0165","first-page":"1213","article-title":"Villous trophoblast of human placenta: a coherent view of its turnover, repair and contributions to villous development and maturation","volume":"16","author":"Mayhew","year":"2001","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.clim.2023.109745_bb0170","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.placenta.2014.01.011","article-title":"Turnover of human villous trophoblast in normal pregnancy: what do we know and what do we need to know?","volume":"35","author":"Mayhew","year":"2014","journal-title":"Placenta."},{"issue":"Suppl A","key":"10.1016\/j.clim.2023.109745_bb0175","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.placenta.2006.01.021","article-title":"Implantation, embryo-maternal interactions, immunology and modulation of the uterine environment \u2013 a workshop report","volume":"27","author":"Moffett","year":"2006","journal-title":"Placenta."},{"key":"10.1016\/j.clim.2023.109745_bb0180","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nri1897","article-title":"Immunology of placentation in eutherian mammals","volume":"6","author":"Moffett","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0897.1992.tb00773.x","article-title":"Immune recognition at the maternal-fetal interface: overview","volume":"28","author":"McIntyre","year":"1992","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0190","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.179.2.457","article-title":"Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface","volume":"179","author":"Matsuura","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2023.109745_bb0195","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/art.39453","article-title":"ApoE receptor 2 mediation of trophoblast dysfunction and pregnancy complications induced by antiphospholipid antibodies in mice","volume":"68","author":"Ulrich","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109745_bb0200","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/CIRCRESAHA.120.318941","article-title":"Protein phosphatase 2A activation via ApoER2 in trophoblasts drives preeclampsia in a mouse model of the antiphospholipid syndrome","volume":"129","author":"Chu","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.clim.2023.109745_bb0205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/molehr\/gaw027","article-title":"Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8","volume":"22","author":"Gysler","year":"2016","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.clim.2023.109745_bb0210","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/art.40416","article-title":"Antiphospholipid antibodies inhibit trophoblast toll-like receptor and inflammasome negative regulators","volume":"70","author":"Mulla","year":"2018","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109745_bb0215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaut.2018.07.002","article-title":"Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome","volume":"93","author":"Ripoll","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2023.109745_bb0220","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/jth.12570","article-title":"Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies","volume":"12","author":"Marchetti","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2023.109745_bb0225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/aji.12130","article-title":"Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of beta glycoprotein I","author":"Di Simone","year":"2013","journal-title":"Am. J. Reprod. Immunol.70"},{"key":"10.1016\/j.clim.2023.109745_bb0230","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2023.109745_bb0235","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/REP-15-0545","article-title":"The role of anti-phospholipid antibodies in autoimmune reproductive failure","volume":"151","author":"Pantham","year":"2016","journal-title":"Reproduction."},{"key":"10.1016\/j.clim.2023.109745_bb0240","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/art.40136","article-title":"Emerging treatment models in rheumatology: antiphospholipid syndrome and pregnancy: pathogenesis to translation","volume":"69","author":"Abrahams","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109745_bb0245","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell."},{"key":"10.1016\/j.clim.2023.109745_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2023.103811","article-title":"Roles of human trophoblasts\u2019 pattern recognition receptors in host defense and pregnancy complications","volume":"156","author":"Motomura","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0255","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.4049\/jimmunol.2300008","article-title":"Comprehensive analysis of the expression and functions of pattern recognition receptors in differentiated cytotrophoblasts derived from term human placentas","volume":"210","author":"Motomura","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0260","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0897.2009.00717.x","article-title":"Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4\/MyD88 pathway","volume":"62","author":"Mulla","year":"2009","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0265","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1600-0897.2009.00805.x","article-title":"Antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity","volume":"63","author":"Mulla","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0270","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1600-0897.2011.01007.x","article-title":"Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin","volume":"66","author":"Carroll","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0275","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/aji.12341","article-title":"Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion","volume":"73","author":"Poulton","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065237","article-title":"A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1beta production by human first trimester trophoblast","volume":"8","author":"Mulla","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109745_bb0285","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2079","article-title":"The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling","volume":"7","author":"O\u2019Neill","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0290","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nri2303","article-title":"Immunobiology of the TAM receptors","volume":"8","author":"Lemke","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0295","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-immunol-032414-112103","article-title":"TAM receptor signaling in immune homeostasis","volume":"33","author":"Rothlin","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0300","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science."},{"key":"10.1016\/j.clim.2023.109745_bb0305","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10059-013-0298-0","article-title":"Crosstalk between autophagy and inflammasomes","volume":"36","author":"Yuk","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.clim.2023.109745_bb0310","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0315","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4161\/auto.22927","article-title":"Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia","volume":"9","author":"Nakashima","year":"2013","journal-title":"Autophagy."},{"key":"10.1016\/j.clim.2023.109745_bb0320","doi-asserted-by":"crossref","first-page":"24851","DOI":"10.1074\/jbc.C200163200","article-title":"The crystal structure of the endothelial protein C receptor and a bound phospholipid","volume":"277","author":"Oganesyan","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2023.109745_bb0325","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.ATV.0000168421.13467.82","article-title":"Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition","volume":"25","author":"Dahlback","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2023.109745_bb0330","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1182\/blood-2017-10-813527","article-title":"Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1","volume":"131","author":"Kondreddy","year":"2018","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0335","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1182\/blood-2014-11-610717","article-title":"EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice","volume":"125","author":"Liang","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0340","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc0956","article-title":"Lipid presentation by the protein C receptor links coagulation with autoimmunity","volume":"371","author":"Muller-Calleja","year":"2021","journal-title":"Science."},{"key":"10.1016\/j.clim.2023.109745_bb0345","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/keab620","article-title":"The pivotal role of endothelial protein C receptor for antiphospholipid antibody-mediated pathologies","volume":"61","author":"Chu","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2023.109745_bb0350","doi-asserted-by":"crossref","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.clim.2023.109745_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158757","article-title":"Identification of a monoclonal antibody that attenuates antiphospholipid syndrome-related pregnancy complications and thrombosis","volume":"11","author":"Mineo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109745_bb0360","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1182\/blood-2017-11-814681","article-title":"Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium","volume":"131","author":"Sacharidou","year":"2018","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0365","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0036-1597286","article-title":"New insights in the pathophysiology of antiphospholipid syndrome","volume":"44","author":"Sacharidou","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.clim.2023.109745_bb0370","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/503712","article-title":"Polymorphism in maternal LRP8 gene is associated with fetal growth","volume":"78","author":"Wang","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2023.109745_bb0375","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1074\/jbc.M114.549014","article-title":"Isoform-specific binding of selenoprotein P to the beta-propeller domain of apolipoprotein E receptor 2 mediates selenium supply","volume":"289","author":"Kurokawa","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2023.109745_bb0380","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1096\/fj.13-231852","article-title":"Maternal-fetal transfer of selenium in the mouse","volume":"27","author":"Burk","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.clim.2023.109745_bb0385","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0002-9378(99)70674-5","article-title":"Annexin V is critical in the maintenance of murine placental integrity","volume":"180","author":"Wang","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clim.2023.109745_bb0390","doi-asserted-by":"crossref","first-page":"42173","DOI":"10.1038\/srep42173","article-title":"Annexin-A5 organized in 2D-network at the plasmalemma eases human trophoblast fusion","volume":"7","author":"Degrelle","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2023.109745_bb0395","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.bbamcr.2008.01.030","article-title":"Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization","volume":"1783","author":"van Genderen","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.clim.2023.109745_bb0400","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.bbamcr.2014.12.038","article-title":"Annexin-A5 promotes membrane resealing in human trophoblasts","volume":"1853","author":"Carmeille","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2023.109745_bb0405","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.placenta.2015.01.193","article-title":"Review: annexin-A5 and cell membrane repair","volume":"36","author":"Bouter","year":"2015","journal-title":"Placenta."},{"key":"10.1016\/j.clim.2023.109745_bb0410","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0002-9378(97)70294-1","article-title":"Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi","volume":"177","author":"Rand","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clim.2023.109745_bb0415","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood.V92.5.1652","article-title":"Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a \u201clupus procoagulant\u201d phenomenon","volume":"92","author":"Rand","year":"1998","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0420","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2006-07-030148","article-title":"Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5","volume":"109","author":"de","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0425","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/hh0102.102795","article-title":"Molecular pathogenesis of the antiphospholipid syndrome","volume":"90","author":"Rand","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.clim.2023.109745_bb0430","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1182\/blood-2004-02-0462","article-title":"Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack","volume":"104","author":"Lieby","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0435","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell."},{"key":"10.1016\/j.clim.2023.109745_bb0440","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.clim.2023.109745_bb0445","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","article-title":"The role of microRNAs in the pathogenesis of autoimmune diseases","volume":"15","author":"Chen","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb0450","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s10735-021-10024-y","article-title":"MiR-133b regulates oxidative stress injury of trophoblasts in preeclampsia by mediating the JAK2\/STAT3 signaling pathway","volume":"52","author":"Yang","year":"2021","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.clim.2023.109745_bb0455","first-page":"10600","article-title":"Effect of miR-133 on apoptosis of trophoblasts in human placenta tissues via Rho\/ROCK signaling pathway","volume":"23","author":"Zhang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.clim.2023.109745_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103281","article-title":"Downregulation of miR-126-3p expression contributes to increased inflammatory response in placental trophoblasts in preeclampsia","volume":"144","author":"Chu","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0465","first-page":"9837","article-title":"MicroRNA-132 stimulates the growth and invasiveness of trophoblasts by targeting DAPK-1","volume":"24","author":"Wang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.clim.2023.109745_bb0470","article-title":"Non-coding RNAs regulate placental trophoblast function and participate in recurrent abortion","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.clim.2023.109745_bb0475","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbrc.2020.06.117","article-title":"circ-ZUFSP regulates trophoblasts migration and invasion through sponging miR-203 to regulate STOX1 expression","volume":"531","author":"Li","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clim.2023.109745_bb0480","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1186\/s12884-020-03345-5","article-title":"circCRAMP1L is a novel biomarker of preeclampsia risk and may play a role in preeclampsia pathogenesis via regulation of the MSP\/RON axis in trophoblasts","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Pregn. Childb."},{"key":"10.1016\/j.clim.2023.109745_bb0485","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s10020-021-00337-9","article-title":"The long noncoding RNA MEG3 regulates Ras-MAPK pathway through RASA1 in trophoblast and is associated with unexplained recurrent spontaneous abortion","volume":"27","author":"Zhang","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.clim.2023.109745_bb0490","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/10715762.2020.1826468","article-title":"Up-regulation of LncRNA NEAT1 induces apoptosis of human placental trophoblasts","volume":"54","author":"Xufei","year":"2020","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.clim.2023.109745_bb0495","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.placenta.2023.04.008","article-title":"Metastasis-associated lung adenocarcinoma transcript 1 induces methyl-CpG-binding domain protein 4 in mice with recurrent spontaneous abortion caused by anti-phospholipid antibody positivity","volume":"137","author":"Han","year":"2023","journal-title":"Placenta."},{"key":"10.1016\/j.clim.2023.109745_bb0500","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fphys.2019.00385","article-title":"The lncRNA MALAT1 rs619586 G variant confers decreased susceptibility to recurrent miscarriage","volume":"10","author":"Che","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.clim.2023.109745_bb0505","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0378(97)00063-6","article-title":"Antiphospholipid antibodies or not? The role of beta 2 glycoprotein 1 in autoantibody-mediated pregnancy loss","volume":"36","author":"Chamley","year":"1997","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0510","article-title":"Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesis","volume":"7","author":"D\u2019Ippolito","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109745_bb0515","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1095\/biolreprod.110.083410","article-title":"Antiphospholipid antibodies affect human endometrial angiogenesis","volume":"83","author":"Di","year":"2010","journal-title":"Biol. Reprod."},{"issue":"Suppl","key":"10.1016\/j.clim.2023.109745_bb0520","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.placenta.2009.12.012","article-title":"Review: Trophoblast-vascular cell interactions in early pregnancy: how to remodel a vessel","volume":"31","author":"Harris","year":"2010","journal-title":"Placenta."},{"key":"10.1016\/j.clim.2023.109745_bb0525","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3389\/fphys.2018.01840","article-title":"Mechanisms of endothelial dysfunction in antiphospholipid syndrome: association with clinical manifestations","volume":"9","author":"Velasquez","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.clim.2023.109745_bb0530","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/19336918.2015.1120397","article-title":"Intrauterine trophoblast migration: a comparative view of humans and rodents","volume":"10","author":"Silva","year":"2016","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.clim.2023.109745_bb0535","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.03.001","article-title":"beta2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis","volume":"55","author":"Raschi","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2023.109745_bb0540","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","article-title":"Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies","volume":"101","author":"Raschi","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0545","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1182\/blood-2011-03-344671","article-title":"A novel pathway for human endothelial cell activation by antiphospholipid\/anti-beta2 glycoprotein I antibodies","volume":"119","author":"Allen","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0550","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1177\/0961203314536479","article-title":"Toll-like receptor 4 and beta2 glycoprotein I interaction on endothelial cells","volume":"23","author":"Borghi","year":"2014","journal-title":"Lupus."},{"key":"10.1016\/j.clim.2023.109745_bb0555","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.21009","article-title":"Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies","volume":"52","author":"Vega-Ostertag","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109745_bb0560","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/intimm\/dxh229","article-title":"Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome","volume":"17","author":"Simoncini","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.706743","article-title":"Antiphospholipid antibodies from women with pregnancy morbidity and vascular thrombosis induce endothelial mitochondrial dysfunction, mTOR activation, and autophagy","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.clim.2023.109745_bb0570","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.semarthrit.2018.08.004","article-title":"Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome","volume":"48","author":"Noureldine","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109745_bb0575","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/art.1780311216","article-title":"HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients","volume":"31","author":"Savi","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109745_bb0580","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/08916939209001909","article-title":"MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study. SLE Study Group","volume":"13","author":"Hartung","year":"1992","journal-title":"Autoimmunity."},{"key":"10.1016\/j.clim.2023.109745_bb0585","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1568-9972(03)00068-5","article-title":"HLA class II alleles and genetic predisposition to the antiphospholipid syndrome","volume":"2","author":"Domenico Sebastiani","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb0590","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/jcp.42.5.495","article-title":"Familial occurrence of the antiphospholipid syndrome","volume":"42","author":"Matthey","year":"1989","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.clim.2023.109745_bb0595","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1191\/0961203303lu402oa","article-title":"HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus","volume":"12","author":"Sebastiani","year":"2003","journal-title":"Lupus."},{"key":"10.1016\/j.clim.2023.109745_bb0600","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/08820130802116117","article-title":"Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations","volume":"37","author":"Sebastiani","year":"2008","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.clim.2023.109745_bb0605","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0610","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.immuni.2005.09.009","article-title":"Unusual features of self-peptide\/MHC binding by autoimmune T cell receptors","volume":"23","author":"Nicholson","year":"2005","journal-title":"Immunity."},{"key":"10.1016\/j.clim.2023.109745_bb0615","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood-2014-08-593624","article-title":"beta2-Glycoprotein I\/HLA class II complexes are novel autoantigens in antiphospholipid syndrome","volume":"125","author":"Tanimura","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0620","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/art.41410","article-title":"The beta (2) -Glycoprotein I\/HLA-DR complex as a major autoantibody target in obstetric antiphospholipid syndrome","volume":"72","author":"Tanimura","year":"2020","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109745_bb0625","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Thery","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.clim.2023.109745_bb0630","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.thromres.2011.08.020","article-title":"Circulating microparticles and risk of venous thromboembolism","volume":"129","author":"Bucciarelli","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2023.109745_bb0635","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3389\/fphys.2019.01236","article-title":"Syncytiotrophoblast-derived extracellular vesicles in pathophysiology of preeclampsia","volume":"10","author":"Han","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.clim.2023.109745_bb0640","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13312","article-title":"Antiphospholipid antibodies and extracellular vesicles in pregnancy","volume":"85","author":"Tong","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0645","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0897.2011.01072.x","article-title":"Circulating cell-derived microparticles in severe preeclampsia and in fetal growth restriction","volume":"67","author":"Alijotas-Reig","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0650","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humrep\/dev278","article-title":"Higher levels of procoagulant microparticles in women with recurrent miscarriage are not associated with antiphospholipid antibodies","volume":"31","author":"Martinez-Zamora","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.clim.2023.109745_bb0655","first-page":"22","article-title":"Extracellular vesicles and antiphospholipid syndrome: state-of-the-art and future challenges","author":"Stok","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2023.109745_bb0660","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/1744666X.2019.1546578","article-title":"Pathogenesis of antiphospholipid syndrome: recent insights and emerging concepts","volume":"15","author":"Lackner","year":"2019","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0665","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/03009742.2017.1372518","article-title":"Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study","volume":"47","author":"Campello","year":"2018","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.clim.2023.109745_bb0670","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/molehr\/gaz019","article-title":"Platelet-derived microparticles from recurrent miscarriage associated with antiphospholipid antibody syndrome influence behaviours of trophoblast and endothelial cells","volume":"25","author":"Zhou","year":"2019","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.clim.2023.109745_bb0675","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.thromres.2014.11.027","article-title":"Endothelial and platelet microparticles in patients with antiphospholipid antibodies","volume":"135","author":"Breen","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2023.109745_bb0680","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.placenta.2009.06.008","article-title":"Anti-phospholipid antibodies increase non-apoptotic trophoblast shedding: a contribution to the pathogenesis of pre-eclampsia in affected women?","volume":"30","author":"Chen","year":"2009","journal-title":"Placenta."},{"key":"10.1016\/j.clim.2023.109745_bb0685","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.placenta.2015.10.006","article-title":"Antiphospholipid antibodies bind syncytiotrophoblast mitochondria and alter the proteome of extruded syncytial nuclear aggregates","volume":"36","author":"Pantham","year":"2015","journal-title":"Placenta."},{"key":"10.1016\/j.clim.2023.109745_bb0690","doi-asserted-by":"crossref","first-page":"16556","DOI":"10.1038\/s41598-017-16448-5","article-title":"Antiphospholipid antibodies increase the levels of mitochondrial DNA in placental extracellular vesicles: Alarmin-g for preeclampsia","volume":"7","author":"Tong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2023.109745_bb0695","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/CS20191245","article-title":"Endoplasmic reticulum stress occurs in association with the extrusion of toxic extracellular vesicles from human placentae treated with antiphospholipid antibodies","volume":"134","author":"Tang","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.clim.2023.109745_bb0700","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","article-title":"HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2023.109745_bb0705","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2567.2007.02662.x","article-title":"The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta","volume":"122","author":"Holmlund","year":"2007","journal-title":"Immunology."},{"key":"10.1016\/j.clim.2023.109745_bb0710","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/aji.12526","article-title":"Immunostimulatory role of mitochondrial DAMPs: alarming for pre-eclampsia?","volume":"76","author":"McCarthy","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0715","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109745_bb0720","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2013.08.005","article-title":"Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris","volume":"47","author":"Viall","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2023.109745_bb0725","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1530\/REP-16-0083","article-title":"Increased levels of HMGB1 in trophoblastic debris may contribute to preeclampsia","volume":"152","author":"Shao","year":"2016","journal-title":"Reproduction."},{"key":"10.1016\/j.clim.2023.109745_bb0730","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.placenta.2012.07.019","article-title":"Antiphospholipid antibodies prolong the activation of endothelial cells induced by necrotic trophoblastic debris: implications for the pathogenesis of preeclampsia","volume":"33","author":"Chen","year":"2012","journal-title":"Placenta."},{"key":"10.1016\/j.clim.2023.109745_bb0735","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.placenta.2017.08.001","article-title":"Melatonin prevents preeclamptic sera and antiphospholipid antibodies inducing the production of reactive nitrogen species and extrusion of toxic trophoblastic debris from first trimester placentae","volume":"58","author":"Zhao","year":"2017","journal-title":"Placenta."},{"key":"10.1016\/j.clim.2023.109745_bb0740","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.604222","article-title":"Exosome-contained APOH associated with antiphospholipid syndrome","volume":"12","author":"Tan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101337","article-title":"Regulation of the complement system and immunological tolerance in pregnancy","volume":"45","author":"Teirila","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0750","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3389\/fimmu.2020.01681","article-title":"Essential role of complement in pregnancy: from implantation to parturition and beyond","volume":"11","author":"Girardi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0755","first-page":"11","article-title":"Variation of complement protein levels in maternal plasma and umbilical cord blood during normal pregnancy: an observational study","author":"Saleh","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.clim.2023.109745_bb0760","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.4049\/jimmunol.0903215","article-title":"An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development","volume":"185","author":"Agostinis","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0765","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2015.02.030","article-title":"The complement system and adverse pregnancy outcomes","volume":"67","author":"Regal","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0770","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1177\/0961203319882507","article-title":"Complementemia in pregnancies with antiphospholipid syndrome","volume":"28","author":"Tabacco","year":"2019","journal-title":"Lupus."},{"key":"10.1016\/j.clim.2023.109745_bb0775","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10067-020-05203-3","article-title":"Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study","volume":"40","author":"Li","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2023.109745_bb0780","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/annrheumdis-2017-212224","article-title":"Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and\/or antiphospholipid antibodies","volume":"77","author":"Kim","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2023.109745_bb0785","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12016-009-8144-z","article-title":"Predictors of pregnancy outcome in antiphospholipid syndrome: a review","volume":"38","author":"De","year":"2010","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0790","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/jth.15082","article-title":"Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications","volume":"19","author":"Chaturvedi","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2023.109745_bb0795","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9060671","article-title":"Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or carriers of antiphospholipid antibodies","volume":"9","author":"Nalli","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.clim.2023.109745_bb0800","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.placenta.2023.04.001","article-title":"Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS registry study group","volume":"136","author":"Esteve-Valverde","year":"2023","journal-title":"Placenta."},{"key":"10.1016\/j.clim.2023.109745_bb0805","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2023.109745_bb0810","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2023.109745_bb0815","first-page":"3453","article-title":"Neutrophil activation by the tissue factor\/Factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome","volume":"118","author":"Redecha","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2023.109745_bb0820","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2007-01-070631","article-title":"Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury","volume":"110","author":"Redecha","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0825","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109745_bb0830","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11926-020-00936-1","article-title":"NETs in APS: current knowledge and future perspectives","volume":"22","author":"Tambralli","year":"2020","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.clim.2023.109745_bb0835","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1111\/jcmm.15321","article-title":"Antiphospholipid antibody-activated NETs exacerbate trophoblast and endothelial cell injury in obstetric antiphospholipid syndrome","volume":"24","author":"Lu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.clim.2023.109745_bb0840","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000134","article-title":"Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies","volume":"3","author":"Marder","year":"2016","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.clim.2023.109745_bb0845","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-cellbio-020520-111016","article-title":"Cellular mechanisms of NETosis","volume":"36","author":"Thiam","year":"2020","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.clim.2023.109745_bb0850","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: a triangular relationship","volume":"16","author":"de Bont","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0855","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/art.41460","article-title":"Anti-Neutrophil extracellular trap antibodies and impaired neutrophil extracellular trap degradation in antiphospholipid syndrome","volume":"72","author":"Zuo","year":"2020","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109745_bb0860","first-page":"66","article-title":"Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome","volume":"32","author":"Leffler","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2023.109745_bb0865","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1095\/biolreprod.116.140293","article-title":"PAD4 deficiency decreases inflammation and susceptibility to pregnancy loss in a mouse model","volume":"95","author":"Erpenbeck","year":"2016","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.clim.2023.109745_bb0870","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1096\/fj.201700399RR","article-title":"Neutrophil extracellular traps are critical for pregnancy loss in sphingosine kinase-deficient mice on 129Sv\/C57BL\/6 background","volume":"31","author":"Mizugishi","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.clim.2023.109745_bb0875","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/art.42489","article-title":"Anti-NET antibodies in antiphospholipid antibody-positive patients: results from the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository","volume":"75","author":"Zuo","year":"2023","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clim.2023.109745_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102982","article-title":"Proteomics and enriched biological processes in Antiphospholipid syndrome: a systematic review","volume":"20","author":"Anunciacion-Llunell","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb0885","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10641955.2019.1640725","article-title":"Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia","volume":"38","author":"Yonekura Collier","year":"2019","journal-title":"Hypertens. Pregn."},{"key":"10.1016\/j.clim.2023.109745_bb0890","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac012","article-title":"Placental sFlt-1 gene delivery in early primate pregnancy suppresses uterine spiral artery remodeling","volume":"163","author":"Aberdeen","year":"2022","journal-title":"Endocrinology."},{"key":"10.1016\/j.clim.2023.109745_bb0895","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fendo.2019.00165","article-title":"Human sFLT1 leads to severe changes in placental differentiation and vascularization in a transgenic hsFLT1\/rtTA FGR mouse model","volume":"10","author":"Vogtmann","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.clim.2023.109745_bb0900","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.ajpath.2015.01.019","article-title":"Placental fractalkine is up-regulated in severe early-onset preeclampsia","volume":"185","author":"Siwetz","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2023.109745_bb0905","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/14767058.2018.1505854","article-title":"Placental fractalkine immunoreactivity in preeclampsia and its correlation with histopathological changes in the placenta and adverse pregnancy outcomes","volume":"33","author":"Usta","year":"2020","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.clim.2023.109745_bb0910","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030641","article-title":"Placental CX3CL1 is deregulated by angiotensin II and contributes to a pro-inflammatory trophoblast-monocyte interaction","volume":"20","author":"Nonn","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2023.109745_bb0915","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1002\/art.23756","article-title":"Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis","volume":"58","author":"Lopez-Pedrera","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109745_bb0920","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1182\/blood-2014-05-577569","article-title":"Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome","volume":"124","author":"Ripoll","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0925","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1210\/er.2014-1045","article-title":"Cyclic decidualization of the human endometrium in reproductive health and failure","volume":"35","author":"Gellersen","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb0930","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/GCO.0b013e328133885f","article-title":"Role of chemokines in the endometrium and in embryo implantation","volume":"19","author":"Hannan","year":"2007","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.clim.2023.109745_bb0935","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/stem.2222","article-title":"Loss of endometrial plasticity in recurrent pregnancy loss","volume":"34","author":"Lucas","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.clim.2023.109745_bb0940","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s42003-020-0763-1","article-title":"Recurrent pregnancy loss is associated with a pro-senescent decidual response during the peri-implantation window","volume":"3","author":"Lucas","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.clim.2023.109745_bb0945","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Coppe","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.clim.2023.109745_bb0950","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1530\/REP-16-0306","article-title":"Success after failure: the role of endometrial stem cells in recurrent miscarriage","volume":"152","author":"Lucas","year":"2016","journal-title":"Reproduction."},{"key":"10.1016\/j.clim.2023.109745_bb0955","first-page":"6","article-title":"Clearance of senescent decidual cells by uterine natural killer cells in cycling human endometrium","author":"Brighton","year":"2017","journal-title":"Elife."},{"key":"10.1016\/j.clim.2023.109745_bb0960","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.42068","article-title":"antiphospholipid antibodies increase endometrial stromal cell decidualization, senescence, and inflammation via toll-like receptor 4, reactive oxygen species, and p38 MAPK signaling","volume":"74","author":"Tong","year":"2022","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109745_bb0965","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1177\/0961203320950461","article-title":"16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends","volume":"29","author":"Cohen","year":"2020","journal-title":"Lupus."},{"key":"10.1016\/j.clim.2023.109745_bb0970","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/biolre\/ioy127","article-title":"Effects of glycol-split low molecular weight heparin on placental, endothelial, and anti-inflammatory pathways relevant to preeclampsia","volume":"99","author":"Wat","year":"2018","journal-title":"Biol. Reprod."},{"issue":"576","key":"10.1016\/j.clim.2023.109745_bb0975","first-page":"e7","article-title":"Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression","volume":"205","author":"Wu","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clim.2023.109745_bb0980","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug","volume":"115","author":"Rand","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb0985","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/aji.12184","article-title":"Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function","volume":"71","author":"Albert","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2023.109745_bb0990","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1111\/jcmm.17459","article-title":"Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome","volume":"26","author":"Liu","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.clim.2023.109745_bb0995","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212614","article-title":"Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: role of reduced inflammation and endothelial dysfunction","volume":"14","author":"Miranda","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109745_bb1000","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaut.2016.04.008","article-title":"Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome","volume":"75","author":"Bertolaccini","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2023.109745_bb1005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ajog.2017.08.113","article-title":"Hydroxychloroquine as additional treatment in pregnant patients with refractory APS","volume":"217","author":"De Carolis","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clim.2023.109745_bb1010","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.autrev.2015.04.010","article-title":"Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?","volume":"14","author":"De Carolis","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb1015","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.autrev.2018.05.012","article-title":"HIBISCUS: hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome","volume":"17","author":"Belizna","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb1020","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1177\/0961203315591027","article-title":"Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study","volume":"24","author":"Leroux","year":"2015","journal-title":"Lupus."},{"key":"10.1016\/j.clim.2023.109745_bb1025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.autrev.2015.01.012","article-title":"The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study","volume":"14","author":"Mekinian","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109745_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.09.078","article-title":"The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies","volume":"214","author":"Sciascia","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.clim.2023.109745_bb1035","first-page":"639","article-title":"Effect of additional treatments combined with conventional therapies in pregnant patients with high-risk antiphospholipid syndrome: a multicentre study","volume":"118","author":"Ruffatti","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.clim.2023.109745_bb1040","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-0037-1603359","volume":"43","author":"Schreiber","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.clim.2023.109745_bb1045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/aji.12102","article-title":"Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside","volume":"69","author":"Bonney","year":"2013","journal-title":"Am. J. Reprod. Immunol."},{"issue":"Suppl A","key":"10.1016\/j.clim.2023.109745_bb1050","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.placenta.2006.11.002","article-title":"Animal models of human placentation \u2013 a review","volume":"28","author":"Carter","year":"2007","journal-title":"Placenta."},{"key":"10.1016\/j.clim.2023.109745_bb1055","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1530\/REP-20-0354","article-title":"Animal models of human pregnancy and placentation: alternatives to the mouse","volume":"160","author":"Carter","year":"2020","journal-title":"Reproduction."},{"key":"10.1016\/j.clim.2023.109745_bb1060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00018-022-04407-x","article-title":"Modelling human placental villous development: designing cultures that reflect anatomy","volume":"79","author":"James","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.clim.2023.109745_bb1065","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.imbio.2014.11.003","article-title":"Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn","volume":"220","author":"Hallstensen","year":"2015","journal-title":"Immunobiology."},{"key":"10.1016\/j.clim.2023.109745_bb1070","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2023.109745_bb1075","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1191\/0961203306lu2315oa","article-title":"A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice","volume":"15","author":"Ostertag","year":"2006","journal-title":"Lupus."},{"key":"10.1016\/j.clim.2023.109745_bb1080","doi-asserted-by":"crossref","first-page":"J209","DOI":"10.1016\/j.jaut.2011.11.009","article-title":"Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the beta2 glycoprotein I phospholipid-binding site. Implications for human fetal loss","volume":"38","author":"de la Torre","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2023.109745_bb1085","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood-2013-11-537704","article-title":"A non-complement-fixing antibody to beta2 glycoprotein I as a novel therapy for antiphospholipid syndrome","volume":"123","author":"Agostinis","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.clim.2023.109745_bb1090","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1538-7836.2011.04327.x","article-title":"beta(2) -Glycoprotein I: evolution, structure and function","volume":"9","author":"de Groot","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2023.109745_bb1095","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1160\/TH11-05-0333","article-title":"Evolutionary conservation of the lipopolysaccharide binding site of beta(2)-glycoprotein I","volume":"106","author":"Agar","year":"2011","journal-title":"Thromb. Haemost."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623005089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623005089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:03:27Z","timestamp":1778616207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623005089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":219,"alternative-id":["S1521661623005089"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109745","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathogenesis of obstetric APS: a 2023 update","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109745"}}